Oncolytic Adenovirus-Based Immunotherapy for Malignant Mesothelioma: Preclinical Advances and Future Perspectives
Malignant mesothelioma is a rare but highly aggressive cancer, with an incidence of approximately 1–2 cases per million per year in industrialized countries and a global annual mortality exceeding 30,000 cases. The disease is caused mainly by exposure to asbestos and is resistant to conventional tre...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2025-07-01
|
| Series: | Postępy Mikrobiologii |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/am-2025-0004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|